A COVID-19 testing laboratory that is surplus to requirements has been put up for sale by the UK government. Like other redundant research facilities before it, there is now an opportunity to build the local life sciences ecosystem

The independent advice panel is at the centre of a transparency row after its report on pharmaceutical innovation was withdrawn, prompting MEPs to challenge its leadership

It is promised as the most important update for more than twenty years, but tensions are high as MEPs struggle to reach a compromise over the EU’s proposed pharmaceutical reform

The landmark pharmaceutical reforms will not be adopted in this mandate, and the opposing views of the two rapporteurs mean the final text may not be ready to hand over to the next parliament, the Science|Business Health innovation conference hears

There is growing pressure on EU policymakers to play a role in promoting the development of psychedelics as medicines. The pharmaceutical regulations reform is an opportunity to incentivise research say MEPs

Europe must give investors certainty by extending data protection for new drugs and facilitating access to market, says senior executive, as the industry continues to contest proposals for the largest reform of EU pharma legislation in over 20 years

Researchers relieved after Commission says there is no need for a legislative proposal to reach the goal of phasing out the use of animals in research, but it will continue to fund the development of alternatives

The initiative is backed by over 1.2 million people - but science and academic groups warn it would be a devastating blow for EU health research. A ban ‘would endanger the lives of millions of people’ says one MEP

Long-awaited Commission proposals to reform EU’s pharmaceutical legislation seek to improve access to medicines and promote innovation, but companies say they will drive investment out of Europe

Freedom of information request shows Biomedical Catalyst is backing only 4% of applications assessed as worthy of funding